Navigation Links
Drug Xeloda as effective as Traditional Chemotherapy

According to Drugmaker Roche Holding AG Xeloda oral chemotherapy is proving to be as effective as traditional chemotherapy to treat advanced stomach cancer//.

Data from a Phase III study which will be presented at an American Society of Clinical Oncology meeting (ASCO) has shown that Xeloda, along with chemotherapy, cisplatin, was found to be as effective as the intravenous chemotherapy with 5-fluorouracil.

This oral drug would significantly decrease the amount of treatment time for patients. And this in turn could prompt healthcare providers to prescribe it over the cheaper although more time-consuming treatment with intravenous chemotherapy, supporting the higher sales potential view of Xeloda.

Currently patients spend almost five days in every three weeks in hospital to receive treatment. Xeloda could reduce that amount of time to only one day, helping patients to live as normally as possible.

Roche claims that gastric cancer has become the fourth commonly diagnosed cancer with a high fatality rate, common more in men than in women, especially among the age group of over 55.

Xeloda already generated 2005 turnover of 796 million francs and is expected to produce a turnover of 2.4 billion francs by 2010, according to Vontobel analyst, Guisep Demont.

. Roche has plans of filing a regulatory approval to treat advanced gastric cancer worldwide.

Xeloda has already been licensed in over 90 countries, with approval to treat colorectal cancer that has spread, and even as a treatment for post-surgery colon cancer in some countries. With various combinations the drug has also been used for forms of breast cancer.


Page: 1

Related medicine news :

1. Morning after pill effective up to five days after having unprotected sex
2. Distraction therapy found very effective in postoperative patients
3. TELITHROMYCIN - the proven effective new drug for cap
4. Digital mammography proves effective
5. Treatment for pre-menstrual syndrome is ineffective
6. Cost-effective antibiotics for sinusitis treatment
7. An effective way to treat angina
8. Fluoride proves effective against fractures
9. Meningitis C vaccine a cost-effective success
10. An effective drug for lung cancer
11. Naltrexone effective for drinking problems
Post Your Comments:

(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
Breaking Medicine Technology: